In search of induction and latency periods: space-time interaction accounting for residential mobility, risk factors and covariates.
BACKGROUND
Space-time interaction arises when nearby cases occur at about the same time, and may be attributable to an infectious etiology or from exposures that cause a geographically localized increase in risk. But available techniques for detecting interaction do not account for residential mobility, nor do they evaluate sensitivity to induction and latency periods. This is an important problem for cancer, where latencies of a decade or more occur.


METHODS
New case-only clustering techniques are developed that account for residential mobility, latency and induction periods, relevant covariates (such as age) and risk factors (such as smoking). The statistical behavior of the methods is evaluated using simulated data to assess type I error (false positives) and statistical power. These methods are applied to 374 cases from an ongoing study of bladder cancer in 11 counties in southeastern Michigan, and the ability of the methods to localize space-time interaction at the individual-level is demonstrated.


RESULTS
Significant interaction is found for induction periods of approximately 5 years and latency approximately 19.5 years. Data are still being collected and the observed clusters may be attributable to differential sampling in the study area.


CONCLUSIONS
Residential histories are increasingly available, raising the possibility of routine surveillance in a manner that accounts for individual mobility and that incorporates models of cancer latency and induction. These new techniques provide a mechanism for identifying those geographic locations and times associated with increases in cancer risk above and beyond that expected given covariates and risk factors in geographically mobile populations.
Jacquez
Geoffrey M
GM
BioMedware, Ann Arbor, USA. jacquez@biomedware.com
Meliker
Jaymie
J
Kaufmann
Andy
A
D000367:Age Factors; D016022:Case-Control Studies; D016000:Cluster Analysis; D018562:Disease Transmission, Infectious; D006801:Humans; D011157:Population Dynamics / Q000639:trends*; D011159:Population Surveillance / Q000379:methods*; D012307:Risk Factors; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology / Q000209:etiology
Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1509-14
16896041
Cancer Res. 1967 Feb;27(2):209-20
6018555
Am J Epidemiol. 2003 May 15;157(10):898-905
12746242
Am J Epidemiol. 1990 Jul;132(1 Suppl):S136-43
2356825
Am J Prev Med. 2006 Feb;30(2 Suppl):S37-49
16458789
Stoch Environ Res Risk Assess. 2007 Aug;21(5):625-634
18560470
Cancer Causes Control. 2005 May;16(4):323-31
15953975
Epidemiology. 1995 Nov;6(6):584-90
8589088
Int Arch Occup Environ Health. 2007 Jan;80(3):184-97
16897097
Int J Health Geogr. 2006;5:32
16887016
Int J Health Geogr. 2006;5:49
17092353
Stat Med. 1996 Sep 15-30;15(17-18):1935-49
8888486
Stat Med. 1995 Jan 15;14(1):3-16
7701156
Am J Epidemiol. 1981 Aug;114(2):253-9
7304560
Environ Health. 2005;4(1):4
15784151
Biometrics. 1999 Jun;55(2):544-52
11318212
Am J Ind Med. 1999 Mar;35(3):246-56
9987557
Int J Health Geogr. 2005 May 18;4:11
15904524
Stat Med. 1995 Apr 30;14(8):799-810
7644860
Stat Med. 1993 Oct;12(19-20):1869-84
8272667
Stat Methods Med Res. 1995 Jun;4(2):124-36
7582201
Int J Health Geogr. 2004 Oct 12;3(1):22
15479473